What is the aim of the proposed trial release of the genetically modified organism GMO What are the benefits of this approach compared with other possible methods especially those not involving planned release

The current vaccine for Hepatitis B is the same cloned viral protein, but delivery is in a pharmacological package designed for injection. Storage and hygiene of injected vaccines have been problematic in rural areas of developing countries where refrigeration and supplies are not readily available. In addition, injections cause significant trauma to children and adults. Packaging the vaccine protein in an edible fruit is a convenient, cost-effective, and humane way of ensuring that adequate doses are delivered to all people in high-risk areas.

0 0

Post a comment